Table 3.
Univariate and multivariate analyses of clinicopathological characteristics and SNHG1 with overall survival for liver cancer patients in TCGA-LIHC cohort.
| Characteristics | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI) | P value | |
| Sex (Male vs. Female) | 0.95 (0.732–1.233) | 0.701 | ||
| Age, years (≥median vs. <median) | 1.248 (0.964–1.617) | 0.093 | ||
| Neoplasm status (tumor free vs. with tumor) | 1.498 (1.151–1.949) | 0.003** | 1.401 (1.071–1.832) | 0.014* |
| Risk factors (alcohol consumption vs. non-alcohol consumption) | 1.114 (0.828–1.499) | 0.476 | ||
| Histologic grade (G1+G2 vs. G3+G4) | 1.227 (0.841–1.79) | 0.289 | ||
| Clinical stage (stage I+II vs. stage III+IV) | 1.523 (1.173–1.975) | 0.002** | 1.421 (1.089–1.855) | 0.012* |
| SNHG1 (≥median vs. <median) | 0.819 (0.63–1.065) | 0.014* | 0.721 (0.459–0.893) | 0.032* |
HR – hazard ratio; CI – confidence interval.
*
p value <0.05;
**
p value <0.01.